Correlation Between Cytosorbents Crp and Electromedical Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cytosorbents Crp and Electromedical Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cytosorbents Crp and Electromedical Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cytosorbents Crp and Electromedical Technologies, you can compare the effects of market volatilities on Cytosorbents Crp and Electromedical Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cytosorbents Crp with a short position of Electromedical Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cytosorbents Crp and Electromedical Technologies.

Diversification Opportunities for Cytosorbents Crp and Electromedical Technologies

0.71
  Correlation Coefficient

Poor diversification

The 3 months correlation between Cytosorbents and Electromedical is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Cytosorbents Crp and Electromedical Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Electromedical Technologies and Cytosorbents Crp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cytosorbents Crp are associated (or correlated) with Electromedical Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Electromedical Technologies has no effect on the direction of Cytosorbents Crp i.e., Cytosorbents Crp and Electromedical Technologies go up and down completely randomly.

Pair Corralation between Cytosorbents Crp and Electromedical Technologies

Given the investment horizon of 90 days Cytosorbents Crp is expected to under-perform the Electromedical Technologies. But the stock apears to be less risky and, when comparing its historical volatility, Cytosorbents Crp is 2.74 times less risky than Electromedical Technologies. The stock trades about -0.03 of its potential returns per unit of risk. The Electromedical Technologies is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  0.10  in Electromedical Technologies on September 20, 2024 and sell it today you would lose (0.07) from holding Electromedical Technologies or give up 70.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Cytosorbents Crp  vs.  Electromedical Technologies

 Performance 
       Timeline  
Cytosorbents Crp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cytosorbents Crp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Electromedical Technologies 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Electromedical Technologies are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, Electromedical Technologies exhibited solid returns over the last few months and may actually be approaching a breakup point.

Cytosorbents Crp and Electromedical Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cytosorbents Crp and Electromedical Technologies

The main advantage of trading using opposite Cytosorbents Crp and Electromedical Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cytosorbents Crp position performs unexpectedly, Electromedical Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Electromedical Technologies will offset losses from the drop in Electromedical Technologies' long position.
The idea behind Cytosorbents Crp and Electromedical Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities